Calumet, Inc. /DE (CLMT): Results of Operations and Financial Condition
Calumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 clmt-20260630xex991.htm EX-99.1 Document Exhibit 99.1 Calumet Reports Second Quarter 2026 Results • Second Quarter 2026 net loss of $(95.9) million, or basic earnings per common share of $(1.09), driven by non-cash RINs and other mark-to-market items • Second Quarter 20
How this was made
The 30-second read
Why it matters
Traders can reassess Calumet’s earnings quality (non-cash RINs and derivatives), operating momentum in Specialty Products and Solutions, and balance-sheet risk after $115M debt retirement and redemption/repayment actions in July.
Market read
A primary earnings release with quantified adjusted EBITDA improvement and explicit July debt reduction, but GAAP losses remain large due to non-cash RINs and mark-to-market items.
What to watch
Segment-level gross profit per barrel swings and LIFO/feedstock impacts could matter more than headline adjusted EBITDA for near-term earnings quality.
Background
SEC Form 8-K Item 2.02 reporting Calumet’s Q2 2026 results and financial condition, including segment performance and recent debt/financing actions.
Ticker impact
Calumet reports Q2 2026 net loss of $95.9M, but highlights $175.2M adjusted EBITDA with tax attributes and $115M debt retirement in July.
Likely choppy reaction: investors may focus on adjusted EBITDA strength and debt paydown, while discounting GAAP loss driven by non-cash RINs and mark-to-market items.
This is a primary SEC 8-K earnings release with multiple actionable datapoints (adjusted EBITDA, segment performance, and specific debt redemption/repayment actions). However, the article does not provide forward guidance or a new capital plan, limiting conviction on direction and magnitude.
Market effects
May signal improving margins/market tightness in specialty products and renewables, relevant to refiners and renewable fuels sentiment.
Limited, company-specific disclosure with no stated regional policy or demand shock.
Low, no international regulatory or macro catalyst beyond commodity-linked items and renewables economics.
Counterpoint
Adjusted EBITDA strength may be partially offset by ongoing volatility in RINs and mark-to-market derivatives, so equity upside could fade if those non-cash drivers reverse.
Key entities
- issuerCalumet, Inc.
NASDAQ-listed specialty products and renewable fuels company reporting Q2 2026 results and deleveraging actions.
- business_segmentMontana Renewables
Renewables segment completing the first phase of MaxSAF 150 expansion and restarting operations in May.
- subsidiaryCalumet Specialty Products Partners, L.P.
Wholly owned subsidiary that redeemed $100M 9.75% Senior Notes due 2028 at a 102.438% redemption price.
